TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment

Santos, C.Lawrence, P.Lopez-Doriga, A.Ragulan, C.Fontana, E.Desai, K.Ps, H.Elez Fernandez, M. E.Aranda Aguilar, E.Losa, F.Paez, D.Layos Romero, L.Sanjuan, X.Canas, M. A.Azuara, D.Queralt, B.Fernandez-Calotti, P.Salazar, R.Sadanandam, A.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/25751enTA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatmentconference outputopen access10.1016/j.annonc.2021.08.9991569-8041http://www.annalsofoncology.org/article/S0923753421032282/pdf700527700456